| O.1 | Approve Financial Statements and Statutory Reports
| Abstain |
| O.2 | Approve Consolidated Financial Statements and Statutory Reports
| Abstain |
| O.3 | Approve Allocation of Income and Dividends of EUR 0.25 per Share With an Option for Payment of Dividends in Cash or in Shares
| For |
| O.4 | Approve Auditors' Special Report on Related-Party Transactions Mentioning the Absence of New Transactions
| For |
| O.5 | Renew Appointment of PricewaterhouseCoopers Audit as Auditor
| Oppose |
| O.6 | Acknowledge End of Mandate of Jean-Christophe Georghiou as Alternate Auditor and Decision Not to Replace and Renew
| For |
| O.7 | Renew Appointment of Mazars as Auditor
| Oppose |
| O.8 | Acknowledge End of Mandate of Jean-Maurice El Nouchi as Alternate Auditor and Decision Not to Replace and Renew
| For |
| O.9 | Approve Remuneration Policy of the Chair and CEO | Oppose |
| O.10 | Approve Remuneration Policy of Directors
| For |
| O.11 | Approve Compensation Report of Corporate Officers
| Oppose |
| O.12 | Approve Compensation of Henri Poupart-Lafarge, Chair and CEO | Oppose |
| O.13 | Authorize Repurchase of Up to 5 Percent of Issued Share Capital
| Oppose |
| E.14 | Authorize Decrease in Share Capital via Cancellation of Repurchased Shares
| For |
| E.15 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans
| Oppose |
| E.16 | Approve All Employee Share Scheme | Oppose |
| E.17 | Authorize Issued Capital for Use in Restricted Stock Plans | Oppose |
| E.18 | Remove Articles Related to Preferred Stock
| For |
| E.19 | Amend Articles of Bylaws to Comply with Legal Changes
| For |
| E.20 | Authorize Capitalization of Reserves of Up to EUR 911 Million for Bonus Issue or Increase in Par Value
| For |
| E.21 | Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 260 Million
| Oppose |
| E.22 | Approve Issuance of Equity or Equity-Linked Securities for Private Placements, up to Aggregate Nominal Amount of EUR 260 Million
| Oppose |
| E.23 | Authorize Capital Increase of up to 10 Percent of Issued Capital for Contributions in Kind
| Oppose |
| E.24 | Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Above
| Oppose |
| E.25 | Authorize Board to Set Issue Price for 10 Percent Per Year of Issued Capital Pursuant to Issue Authority without Preemptive Rights
| Oppose |
| E.26 | Authorize Capital Increase of Up to EUR 260 Million for Future Exchange Offers
| Oppose |
| E.27 | Approve Issuance of Equity or Equity-Linked Securities for Reserved for Specific Beneficiaries, up to Aggregate Nominal Amount of EUR 260 Million
| Oppose |
| O.28 | Authorize Filing of Required Documents/Other Formalities
| For |
